Skip to main content

Advertisement

SpringerLink
Log in

Treatment response evaluation by MRI in breast cancer patients receiving neoadjuvant chemotherapy: there is more than just pathologic complete response prediction

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wu L, Hu J, Gu H, Hua J, Chen J, Xu R (2012) Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer? Breast Cancer Res Treat [Epub ahead of print, April 4]

  2. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN (2007) Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 608:1–22

    Article  PubMed  CAS  Google Scholar 

  3. Partridge SC, Gibbs JE, Lu Y et al (2002) Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179:1193–1199

    PubMed  Google Scholar 

  4. Cheung Y, Chen S, Su M et al (2003) Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. Breast Cancer Res Treat 78:51–58

    Article  PubMed  CAS  Google Scholar 

  5. Nakahara H, Yasuda Y, Machida E et al (2011) MR and US imaging for breast cancer patients who underwent conservation surgery after neoadjuvant chemotherapy: comparison of triple negative breast cancer and other intrinsic subtypes. Breast Cancer 18:152–160

    Article  PubMed  Google Scholar 

  6. Yeh E, Slanetz P, Kopans DB et al (2005) Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184:868–877

    PubMed  Google Scholar 

  7. Belli P, Costantini M, Malaspina C, Magistrelli A, LaTorre G, Bonomo L (2006) MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy. Clin Radiol 61:946–953

    Article  PubMed  CAS  Google Scholar 

  8. Kim HJ, Im Y, Han B et al (2007) Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: relation to response patterns on MRI. Acta Oncol 46:996–1003

    Article  PubMed  Google Scholar 

  9. Segara D, Krop IE, Garber JE et al (2007) Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy? J Surg Oncol 96:474–480

    Article  PubMed  Google Scholar 

  10. Denis F, Desbiez-Bourcier AV, Chapiron C, Arbion F, Body G, Brunereau L (2004) Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. Eur J Surg Oncol 30:1069–1076

    Article  PubMed  CAS  Google Scholar 

  11. Loo CE, Straver ME, Rodenhuis S et al (2011) Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype. J Clin Oncol 29:660–666

    Article  PubMed  Google Scholar 

  12. Chen JH, Feig B, Agrawal G et al (2008) MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer 112:17–26

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The author reports no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Radiology, Maastricht University Medical Center, Maastricht, The Netherlands

    M. B. I. Lobbes

  2. GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands

    M. B. I. Lobbes

Authors
  1. M. B. I. Lobbes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. B. I. Lobbes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lobbes, M.B.I. Treatment response evaluation by MRI in breast cancer patients receiving neoadjuvant chemotherapy: there is more than just pathologic complete response prediction. Breast Cancer Res Treat 136, 313–314 (2012). https://doi.org/10.1007/s10549-012-2180-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-012-2180-8

Keywords

Search

Navigation